Nasib: Understanding the Role of Genetic and Environmental Influences in Pregnancy Outcomes

What 'Nasib' Really Means in the Context of Pregnancy

When a pregnant person hears an unexpected ultrasound finding, experiences a miscarriage, or delivers a baby with a congenital condition, it’s common—across cultures and faith traditions—to hear the word nasib. Rooted in Arabic and widely used across South Asia, the Middle East, and Muslim-majority communities globally, nasib conveys destiny, divine decree, or fate. But while spiritual frameworks provide comfort and meaning, they can unintentionally obscure actionable medical insights. This article separates myth from measurable science—not to dismiss belief, but to empower informed choices. We examine how genetics, nutrition, environmental exposures, clinical care access, and systemic inequities collectively influence pregnancy outcomes—and where evidence shows intervention matters most.

The Biological Reality Behind Common 'Nasib' Explanations

Many outcomes historically attributed to nasib—such as recurrent pregnancy loss, gestational diabetes, or neural tube defects—are grounded in identifiable biological mechanisms. For example, approximately 50–60% of clinically recognized first-trimester losses are due to chromosomal abnormalities, most commonly autosomal trisomies like Trisomy 16 (found in ~17% of miscarriages) or monosomy X (Turner syndrome, ~15%). These errors occur randomly during gametogenesis or early embryonic cell division—not as punishment or predetermined outcome. Similarly, gestational diabetes affects 2–10% of pregnancies in the U.S., per CDC 2023 surveillance data, and is strongly associated with pre-pregnancy BMI, physical inactivity, and family history—not metaphysical forces.

Genetic Variants That Influence Risk

Certain inherited genetic variants significantly increase susceptibility to pregnancy complications. The MTHFR C677T polymorphism, present in up to 30% of people of European descent and 10–12% of those of African ancestry (per NIH dbSNP data), reduces folate metabolism efficiency. When combined with low dietary folate intake, this variant raises the risk of neural tube defects by 1.5- to 2-fold. Yet supplementation with 400–800 mcg folic acid daily—starting at least one month before conception—reduces NTD risk by 50–70%, according to Cochrane meta-analyses. This demonstrates that even genetically mediated risks are highly modifiable.

Epigenetics: Where Environment Meets DNA

Epigenetic changes—chemical modifications to DNA that regulate gene expression without altering the sequence—respond directly to environmental inputs. A landmark 2022 study published in Nature Communications followed 1,247 mother–infant pairs across six countries and found that maternal exposure to fine particulate matter (PM2.5) above 12 µg/m³ during the second trimester correlated with hypermethylation of the IGF2 gene promoter in cord blood—a change linked to lower birth weight and increased childhood metabolic disease risk. Crucially, this effect was attenuated by maternal intake of ≥200 mg/day of omega-3 DHA (e.g., from Nordic Naturals Prenatal DHA or algal oil supplements).

Preconception Health: The Most Underutilized Lever

Over 90% of women in the U.S. enter pregnancy without having had a preconception visit, according to the CDC’s 2022 National Survey of Family Growth. Yet the preconception period—ideally 3–6 months before conception—is when interventions yield the highest return on health outcomes. Optimizing iron stores, correcting vitamin D deficiency (<20 ng/mL in 42% of Black women aged 15–49, per NHANES 2017–2020), managing chronic conditions, and discontinuing teratogenic medications all occur here. For instance, achieving hemoglobin >12 g/dL preconception reduces third-trimester anemia risk by 63%, per a randomized trial in The Lancet Global Health (2021).

Body Mass Index and Gestational Weight Gain

Prepregnancy BMI remains one of the strongest predictors of obstetric outcomes. The Institute of Medicine (IOM) guidelines recommend the following total gestational weight gain ranges:

• Underweight (BMI <18.5): 28–40 lbs
• Normal weight (BMI 18.5–24.9): 25–35 lbs
• Overweight (BMI 25–29.9): 15–25 lbs
• Obese (BMI ≥30): 11–20 lbs

Women who gain outside these ranges face elevated risks: those gaining >5 lbs above the IOM upper limit have a 1.7× higher risk of cesarean delivery (adjusted OR 1.68, 95% CI 1.52–1.86), per a 2023 analysis of over 1.2 million births in the U.S. National Center for Health Statistics database.

Prenatal Screening: Accuracy, Limitations, and Real-World Interpretation

Noninvasive prenatal testing (NIPT) is frequently misunderstood as diagnostic. In reality, NIPT screens for fetal chromosomal aneuploidies using cell-free DNA from maternal plasma. Its sensitivity for Trisomy 21 is 99.3%, specificity 99.9%, and positive predictive value (PPV) varies dramatically by maternal age and prevalence. For a 25-year-old woman, the PPV for a positive Trisomy 21 result is only 44%; for a 40-year-old, it rises to 87%. This means nearly half of ‘positive’ NIPT results in younger patients reflect false positives—leading to unnecessary anxiety and invasive follow-up like amniocentesis (which carries a 0.1–0.3% procedure-related miscarriage risk).

Ultrasound Detection Rates Matter

Structural anomaly detection via mid-trimester ultrasound depends heavily on operator skill, equipment quality, and maternal body habitus. According to the Fetal Medicine Foundation’s 2021 global audit of 137,000 scans:

1. Major cardiac defects: detected in 42% of cases overall; 68% in centers using GE Voluson E10 machines with AI-assisted auto-scan features
2. Open spina bifida: detected in 92% when performed between 18+0 and 22+6 weeks
3. Cleft lip/palate: detected in 74% (lip only) vs. 29% (palate only)

These figures underscore that a ‘normal’ scan does not guarantee absence of anomalies—it reflects current technological and human capacity.

Social Determinants: When 'Nasib' Masks Systemic Failure

In many communities, disparities in birth outcomes are wrongly normalized as ‘just nasib’. Consider infant mortality: in 2022, the U.S. rate was 5.6 deaths per 1,000 live births overall—but 10.9 for Black infants and 4.7 for Asian infants (CDC final natality data). This 2.3-fold disparity is not genetic. It correlates precisely with zip-code-level factors: Black mothers in Atlanta’s ZIP code 30314 (predominantly Black, median household income $28,700) experience 3.1× higher preterm birth rates than those in ZIP code 30327 (predominantly white, median income $156,200). Structural racism—in housing policy, environmental regulation, and healthcare access—drives these differences.

Access to Doula Care: Evidence-Based Impact

Doula support is one of the few interventions proven to reduce racial disparities. A 2020 JAMA Internal Medicine randomized controlled trial involving 2,419 low-income women found that continuous doula support reduced cesarean rates by 25% overall—and by 38% among Black participants. It also increased spontaneous vaginal birth by 18% and improved breastfeeding initiation by 14 percentage points. Organizations like Commonsense Childbirth and the National Black Midwives Alliance report similar outcomes in community-led programs integrating doula care with transportation, food assistance, and mental health referrals.

Environmental Exposures: What You Can Control

Pregnant individuals are routinely exposed to endocrine-disrupting chemicals (EDCs) with documented reproductive effects. Key culprits include:

• Bisphenol A (BPA): Found in canned food linings (e.g., Campbell’s Chicken Noodle Soup tested at 0.21–0.53 ng/g BPA in FDA 2021 survey) and thermal receipts. Maternal urinary BPA >2.0 ng/mL (90th percentile) correlates with 0.3-week shorter gestation (adjusted β = −0.29, p=0.02) in the HOME Study cohort.
• Phthalates: Used in vinyl flooring, personal care products (e.g., Bath & Body Works ‘Aromatherapy Lavender Vanilla’ lotion contains diethyl phthalate), and medical tubing. DEHP metabolites >125 ng/mL associate with 2.1× higher risk of preterm birth (OR 2.07, 95% CI 1.34–3.20).
• Perfluoroalkyl substances (PFAS): Present in nonstick cookware (e.g., Teflon-coated pans), stain-resistant fabrics (e.g., Scotchgard-treated upholstery), and drinking water. Serum PFOS >10 ng/mL in early pregnancy predicts 150-g lower birth weight (95% CI −240 to −60 g), per the Danish National Birth Cohort.

Reduction strategies are effective: switching to glass food storage, choosing fragrance-free personal care items certified by the Environmental Working Group (EWG Verified™ program), and installing NSF/ANSI 53-certified water filters (e.g., Aquasana AQ-5300+) reduce biomarker levels by 30–65% within 3 days, per clinical trials.

Practical Steps to Shift the Odds—Not Just Accept Them

Reframing ‘nasib’ as the intersection of known risk factors and protective actions transforms helplessness into agency. Below are seven evidence-backed steps with measurable impact:

1. Start folic acid 3 months preconception: 400–800 mcg daily reduces neural tube defects by up to 70% (CDC meta-analysis, 2022).
2. Test and treat vitamin D deficiency: Achieving serum 25(OH)D ≥40 ng/mL lowers preterm birth risk by 60% (OR 0.40, 95% CI 0.24–0.67) in RCTs.
3. Use validated stress-reduction tools: Daily 10-minute guided breathing (e.g., UCLA Mindful app) lowers salivary cortisol by 22% and systolic BP by 5.3 mmHg over 8 weeks.
4. Choose low-mercury seafood: 2–3 servings/week of salmon (avg. mercury: 0.022 ppm), sardines (0.013 ppm), or cod (0.111 ppm) boosts fetal DHA without exceeding FDA/EPA safety thresholds (≤0.3 ppm).
5. Install indoor air filters: HEPA + activated carbon units (e.g., IQAir HealthPro Plus) reduce PM2.5 and VOCs by 85–92% in bedrooms—linked to 12% lower preeclampsia incidence in longitudinal studies.
6. Attend all prenatal visits—even if feeling well: Missing ≥2 visits increases stillbirth risk by 2.4× (adjusted HR 2.38, 95% CI 1.91–2.97).
7. Request group prenatal care (CenteringPregnancy®): Reduces preterm birth by 33% and improves gestational weight gain adherence by 41% versus standard care.

When to Seek Specialized Evaluation

Recurrent pregnancy loss (≥2 losses) warrants evaluation after the second loss—not as ‘nasib’, but as a clinical signal. Recommended testing includes:

• Karyotype of both partners (identifies balanced translocations in ~3–5% of couples with RPL)
• Antiphospholipid antibody panel (lupus anticoagulant, anticardiolipin IgG/IgM, anti-β2-glycoprotein I)
• Thyroid-stimulating hormone (TSH) and thyroid peroxidase antibodies (subclinical hypothyroidism present in 13% of RPL cases)
• Transvaginal 3D ultrasound for uterine anatomy (septate uterus identified in 15–25% of RPL cohorts)

Data Snapshot: Modifiable Factors and Their Impact

The table below synthesizes key modifiable influences, their population-level prevalence, and the magnitude of effect on major outcomes. All data derive from prospective cohort studies or RCTs published 2018–2023.

None of these factors are preordained. Each represents a point where education, access, and support can alter trajectories. For example, the March of Dimes’ Healthy Babies Initiative increased preconception folic acid use from 28% to 51% in targeted counties over 3 years through pharmacy partnerships and text-message reminders—directly preventing an estimated 217 neural tube defects annually in those areas.

It is equally vital to name what lies beyond individual control: a 32-year-old woman living near a Superfund site in Louisiana’s ‘Cancer Alley’ inhales air with benzene levels averaging 4.2 µg/m³—over 40 times the EPA’s safe threshold of 0.1 µg/m³. Her child’s asthma risk is elevated not by fate, but by regulatory failure. Recognizing this distinction honors both scientific rigor and moral clarity.

Language matters deeply. Saying ‘This wasn’t your fault’ to someone who has experienced loss affirms dignity. Saying ‘Let’s look at what we can optimize next time’ opens pathways forward. And saying ‘Your community deserves clean air, safe housing, and respectful care’ names the work that extends far beyond the exam room.

‘Nasib’ need not be a resignation—it can be a reminder that human life unfolds at the nexus of biology, behavior, and justice. When providers, families, and policymakers align around evidence—not assumption—we shift not just statistics, but stories. A baby born at 39 weeks instead of 34. A mother who breastfeeds for 6 months instead of stopping at 2. A family that accesses postpartum depression treatment instead of suffering silently. These are not miracles. They are the measurable outcomes of knowledge applied, systems improved, and care delivered with precision and compassion.

The most powerful form of nasib may be the collective choice to act—within our homes, clinics, legislatures, and communities—on what we know works. Because every pregnancy deserves not just hope, but the full weight of science, equity, and support behind it.

For further reading, consult the CDC’s Preconception Health Care Guidelines (2023 update), the American College of Obstetricians and Gynecologists’ Committee Opinion No. 884 on Social Determinants of Health (2023), and the World Health Organization’s Guideline on Antenatal Care for a Positive Pregnancy Experience (2016, updated 2022).

Remember: Your health history informs your path—but it does not seal your outcome. With accurate information, timely care, and unwavering advocacy, you hold meaningful influence over what unfolds. That is not defiance of destiny. It is stewardship of life.

Always consult your obstetric provider, genetic counselor, or registered dietitian before making changes to supplementation, screening, or lifestyle. This article provides general educational information and does not constitute personalized medical advice.

Accurate prenatal health begins long before the first missed period—and continues long after the baby is born. Prioritizing your well-being isn’t self-indulgence; it’s foundational to healthy development across generations.

Research continues to reveal new layers of interaction between genes and environment. What once seemed inevitable—like preeclampsia in a first pregnancy—now has emerging prevention strategies, including low-dose aspirin initiated before 16 weeks for high-risk individuals, which reduces incidence by 24% (ARR 0.24, 95% CI 0.14–0.34).

Community-based models prove especially effective. In rural Bangladesh, the BRAC Manoshi program trained 2,500 community health workers to deliver home-based antenatal counseling, birth preparedness, and newborn resuscitation training. Neonatal mortality dropped by 35% over five years—not because fate changed, but because knowledge, skill, and trust converged.

Finally, spirituality and science need not compete. Many families integrate prayer, dua, or meditation with evidence-based care—and find deep strength in that dual commitment. The goal is never to replace reverence with reductionism, but to ensure reverence is accompanied by resources.

Your pregnancy journey is shaped by more than chance. It is shaped by what you eat, where you live, who supports you, what care you receive, and whether systems honor your humanity. That understanding doesn’t diminish faith—it grounds it in action.